The Effect of Dupilumab on Lung Inflammation and Related Changes in Airway Volumes Detectable by Functional Respiratory Imaging in Patients With Moderate-severe Asthma

PHASE4CompletedINTERVENTIONAL
Enrollment

109

Participants

Timeline

Start Date

June 20, 2020

Primary Completion Date

June 26, 2023

Study Completion Date

August 21, 2023

Conditions
Asthma
Interventions
DRUG

Dupilumab

solution for injection subcutaneous

DRUG

Placebo

Solution for injection subcutaneous

Trial Locations (65)

110

Investigational Site Number : 1580001, Taipei

704

Investigational Site Number : 1580003, Tainan City

807

Investigational Site Number : 1580004, Kaohsiung City

1000

Investigational Site Number : 1000015, Sofia

1202

Investigational Site Number : 1000005, Sofia

1233

Investigational Site Number : 1000003, Sofia

Investigational Site Number : 1000006, Sofia

1407

Investigational Site Number : 1000011, Sofia

1431

Investigational Site Number : 1000010, Sofia

1680

Investigational Site Number : 1000002, Sofia

2100

Investigational Site Number : 2080002, Copenhagen

2400

Investigational Site Number : 2080003, Copenhagen Nv

2600

Investigational Site Number : 1000013, Dupnitsa

2650

Investigational Site Number : 2080001, Hvidovre

3403

Investigational Site Number : 1000004, Montana

4000

Investigational Site Number : 1000018, Plovdiv

4002

Investigational Site Number : 1000012, Plovdiv

6001

Investigational Site Number : 1000007, Stara Zagora

7002

Investigational Site Number : 1000008, Rousse

8200

Investigational Site Number : 2080006, Aarhus N

11426

Investigational Site Number : 6820006, Riyadh

11525

Investigational Site Number : 6820001, Riyadh

12372

Investigational Site Number : 6820002, Riyadh

12746

Investigational Site Number : 6820010, Riyadh

15706

Investigational Site Number : 7240002, Santiago de Compostela

20089

Investigational Site Number : 3800004, Rozzano

21423

Investigational Site Number : 6820004, Jeddah

28041

Investigational Site Number : 7240005, Madrid

28046

Investigational Site Number : 7240003, Madrid

28277

American Health Research Site Number : 8400005, Charlotte

29303

VitaLink Research - Spartanburg Site Number : 8400011, Spartanburg

~Spartanburg Medical Research Site Number : 8400004, Spartanburg

29425

Medical University of South Carolina - Pulmonary & Critical Care Clinical Research Program Site Number : 8400009, Charleston

29615

VitaLink Research-Greenville Site Number : 8400013, Greenville

31952

Investigational Site Number : 6820008, Dammam

40447

Investigational Site Number : 1580002, Taichung

44124

Investigational Site Number : 3800003, Cona

46000

Investigational Site Number : 8040007, Ternopil

48109

University of Michigan Site Number : 8400002, Ann Arbor

56124

Investigational Site Number : 3800001, Pisa

58001

Investigational Site Number : 8040003, Chernivtsi

61124

Investigational Site Number : 8040002, Kharkiv

63017

The Lung Research Center Site Number : 8400010, Chesterfield

65025

Investigational Site Number : 8040005, Odesa

66103

University of Kansas School of Medicine Site Number : 8400008, Kansas City

76018

Investigational Site Number : 8040001, Ivano-Frankivsk

92683

Allianz Research Institute Site Number : 8400020, Westminster

97504

Velocity Clinical Research, Medford Site Number : 8400014, Medford

300134

Investigational Site Number : 6420003, Timișoara

400275

Investigational Site Number : 6420006, Cluj-Napoca

400371

Investigational Site Number : 6420001, Cluj-Napoca

410155

Investigational Site Number : 6420007, Oradea

500283

Investigational Site Number : 6420008, Brasov

769764

Investigational Site Number : 6420005, Bragadiru

Unknown

Investigational Site Number : 2500001, Montpellier

3000-075

Investigational Site Number : 6200004, Coimbra

4810-061

Investigational Site Number : 6200005, Guimarães

1649-035

Investigational Site Number : 6200006, Lisbon

4100-180

Investigational Site Number : 6200003, Porto

4202-451

Investigational Site Number : 6200001, Porto

08035

Investigational Site Number : 7240001, Barcelona

221 85

Investigational Site Number : 7520001, Lund

01023

Investigational Site Number : 8040004, Kyiv

LE3 9QP

Investigational Site Number : 8260001, Leicester

BD9 6RJ

Investigational Site Number : 8260002, Bradford

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Regeneron Pharmaceuticals

INDUSTRY

lead

Sanofi

INDUSTRY